Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesSolarvest Bioenergy Inc

Solarvest Bioenergy Inc

Healthcare Biotechnology
PortfolioPortfolio WatchlistWatchlist
Company price
None CAD 0.00(0%)
Last update at 2024-02-15T20:03:42.180983Z
Market Cap
1.52M

Momentum Score

…

Solarvest BioEnergy Inc. engages in the development of algal-based production systems to produce natural based green commercial products. It provides human nutrition products, including omega-3; clean energy production system that enables for continuous hydrogen production; and active ingredients for human health comprising cannabinoids in algae and bone morphogenetic protein for the treatment of repairing bone fractures. Solarvest BioEnergy Inc. has a collaborative research and development agreement with FSD Pharma Inc. to produce cannabidiol (CBD), Cannabigerol (CBG), and tetrahydrocannabinol (THC) programs. The company was incorporated in 2005 and is based in Vancouver, Canada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

52 Week Price Range
0.01
Low
0.11
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
0.03
Dividend Yield
-
Revenue TTM
0.00M
Revenue Per Share
-
Gross Profit TTM
-0.01M
Debt / Equity
-
ROE
-
Net Debt
2.76M
ROCE
43.81%
Diluted EPS TTM
-0.04

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-07-31 2022-07-31 2021-07-31 2020-07-31 2019-07-31
Type yearly yearly yearly yearly yearly
Date 2023-07-31 2022-07-31 2021-07-31 2020-07-31 2019-07-31
Income before tax -2.41M -1.63M -3.46M -1.54M -1.39M
Net income -2.41M -1.63M -3.46M -1.54M -1.39M
Selling general administrative 1.08M 0.46M 1.27M 0.52M 0.49M
Gross profit 0.00M -0.00M 0.00M - -0.01M
Reconciled depreciation 0.06M 0.09M 0.09M 0.11M 0.10M
Ebit - -1.52M -2.33M -1.47M -1.27M
Ebitda - -1.45M -3.26M -1.37M -1.25M
Operating income -2.22M -1.54M -2.38M -1.48M -1.32M
Interest expense 0.12M 0.09M 0.11M 0.00M 0.04M
Net interest income -0.12M -0.09M -0.11M -0.11M -0.08M
Total revenue 0.00M 0.00M 0.00M 0.01M 0.00M
Total operating expenses 2.22M 1.54M 2.38M 1.49M 1.32M
Cost of revenue 0.00M 0.00M 0.00M - 0.01M
Total other income expense net -0.07M 0.01M -0.97M 0.04M 0.01M
Net income from continuing ops -2.41M -1.63M -3.46M -1.54M -1.39M
Net income applicable to common shares - -1.63M -3.46M -1.54M -1.39M
Breakdown 2023-07-31 2022-07-31 2021-07-31 2020-07-31 2019-07-31
Type yearly yearly yearly yearly yearly
Date 2023-07-31 2022-07-31 2021-07-31 2020-07-31 2019-07-31
Total assets 0.63M 1.19M 2.30M 3.07M 3.62M
Intangible assets 0.16M 0.18M 0.21M 0.23M 0.25M
Other current assets - - - 0.96M 1.80M
Total liab 6.25M 5.22M 4.70M 5.45M 4.83M
Total stockholder equity -5.62M -4.03M -2.40M -2.38M -1.20M
Other current liab - 0.10M 0.02M 0.01M 1.10M
Common stock - 9.93M 9.93M 7.40M 7.00M
Capital stock 10.26M 9.93M 9.93M 7.40M 7.00M
Retained earnings -18.96M -16.54M -14.91M -11.45M -9.88M
Other liab - - 0.79M - -
Cash 0.02M 0.02M 1.39M 0.55M 0.06M
Total current liabilities 5.70M 1.25M 0.94M 2.36M 2.15M
Net debt 2.76M 2.89M 1.45M 2.41M 2.85M
Short term debt - - - - 0.23M
Short long term debt 2.76M 0.21M 0.16M 0.20M 0.23M
Other stockholder equity - - 0.88M 1.04M 1.16M
Property plant equipment - 0.54M 0.57M 0.70M 0.40M
Total current assets 0.03M 0.47M 1.53M 2.13M 2.97M
Net tangible assets - -4.21M -2.61M -2.61M -1.46M
Short term investments - - 0.00M 0.60M 1.10M
Net receivables 0.01M 0.01M 0.02M 0.98M 1.81M
Long term debt 0.03M 2.69M 2.68M 2.76M 2.68M
Inventory 0.00M 0.41M 0.10M - -
Accounts payable 0.72M 0.70M 0.52M 1.17M 0.81M
Non currrent assets other - - - - 0.65M
Non current assets total 0.60M 0.72M 0.77M 0.93M 0.65M
Capital lease obligations 0.00M 0.29M 0.33M 0.37M -
Breakdown 2023-07-31 2022-07-31 2021-07-31 2020-07-31 2019-07-31
Type yearly yearly yearly yearly yearly
Date 2023-07-31 2022-07-31 2021-07-31 2020-07-31 2019-07-31
Investments -0.29M -0.03M 0.26M 1.42M 0.10M
Change to liabilities - 0.26M -0.46M 0.44M -0.02M
Total cashflows from investing activities - -0.03M 0.64M 1.40M 0.10M
Net borrowings - 0.18M -0.17M 0.11M 0.01M
Total cash from financing activities 1.42M 0.18M 2.66M 0.11M 1.07M
Change to operating activities - -0.01M -0.01M -0.00M -0.00M
Net income -2.41M -1.63M -3.46M -1.54M -1.39M
Change in cash 0.00M -1.37M 0.84M 0.49M -0.07M
Begin period cash flow 0.02M 1.39M 0.55M 0.06M 0.13M
End period cash flow 0.02M 0.02M 1.39M 0.55M 0.06M
Total cash from operating activities -1.13M -1.52M -2.46M -1.02M -1.24M
Issuance of capital stock 0.54M 0.00M 2.88M - 1.18M
Depreciation 0.06M 0.09M 0.09M 0.11M 0.10M
Change to inventory -0.05M -0.31M -0.10M -0.10M -0.10M
Change to account receivables 0.00M 0.01M 0.00M -0.01M 0.00M
Other cashflows from financing activities - - -0.05M -0.05M -0.11M
Change to netincome - 0.07M 1.48M -0.02M 0.06M
Capital expenditures 0.31M 0.03M 0.02M 0.02M 0.01M
Change in working capital 0.23M -0.05M -0.58M 0.44M -0.01M
Stock based compensation 0.34M 0.00M 0.44M - -
Other non cash items 0.12M 0.07M 0.06M 0.03M 0.06M
Free cash flow -1.44M -1.56M -2.48M -1.04M -1.25M

Peer Comparison*

Sector: Healthcare Industry: Biotechnology

Stock Name
Change
(CAD)
Price
(CAD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
SHRX
Sharp Therapeutics Corp.		 -
-%		 1.37 - - - 32.37 - -
NRX
NurExone Biologic Inc.		 -0.01
2.00%		 0.49 - 6.90 - 15.26 - -7.24
MIR
MedMira Inc		 -
-%		 0.06 - - 223.37 - 293.42 -80.03
TTI
Thiogenesis Therapeutics Corp.		 -
-%		 0.63 - - - 15.17 - -58.16

Profile*

Solarvest Bioenergy Inc

Solarvest BioEnergy Inc. engages in the development of algal-based production systems to produce natural based green commercial products. It provides human nutrition products, including omega-3; clean energy production system that enables for continuous hydrogen production; and active ingredients for human health comprising cannabinoids in algae and bone morphogenetic protein for the treatment of repairing bone fractures. Solarvest BioEnergy Inc. has a collaborative research and development agreement with FSD Pharma Inc. to produce cannabidiol (CBD), Cannabigerol (CBG), and tetrahydrocannabinol (THC) programs. The company was incorporated in 2005 and is based in Vancouver, Canada.

439 Helmcken Street, Vancouver, BC, Canada, V6B 2E6

674 204 4095

https://www.solarvest.ca

Name Title Year Born
Mr. Gerri J. Greenham Pres 1951
Mr. Gerard Watts Interim Chief Financial Officer NA
Mr. Garth Greenham Chief Operating Officer NA
Mr. Claes Ellegaard CEO & Additional Director NA
Mr. Richard T. Groome BA Chairman of Financial Advisory Committee 1959

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

PRL
CAD 30.50
+15.05%
DSV
CAD 11.02
+14.55%
USA
CAD 4.29
+13.19%
NUAG
CAD 7.70
+12.90%
GMIN
CAD 43.79
+12.86%
DRUG
CAD 26.11
-29.58%
HUT
CAD 68.98
-22.41%
UCU
CAD 2.09
-14.34%
VET
CAD 14.87
-14.29%
PHX
CAD 10.96
-13.56%

Equity Sectors*

  • Basic Materials

    +5.46%

  • Communication Services

    +3.38%

  • Consumer Cyclical

    +3.11%

  • Consumer Defensive

    +1.35%

  • Energy

    -4.79%

  • Financial Services

    +2.66%

  • Healthcare

    -0.72%

  • Industrials

    -0.11%

  • Real Estate

    +1.84%

  • Technology

    +1.05%

  • Utilities

    +0.39%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…